Skip to content

DBV Technologies DBVT Operating margin

Operating margin at other companies

Avalo Therapeutics logo
Avalo TherapeuticsAVTX
-15,536.1%-17,275pp
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
-35,688.5%-39,114pp
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
-242%
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
-697.7%+635pp
Alumis Inc. logo
Alumis Inc.ALMS
-5,364%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
24.3%-2.9pp

Other financials

Income statement

See full
Revenue$900.0K+12.5%
Operating income-$47.9M-80.1%
Net income-$47.6M-75.6%
EPS (diluted)-$0.11+57.7%

Balance sheet

See full
Cash & equivalents$229.2M+1,668%
Total debt$6.1M-15.7%
Total equity$207.9M+7,069%
Total assets$266.4M+427%

Cash flow

See full
Operating cash flow-$49.1M-149%
CapEx$400.0K
Free cash flow-$49.5M-151%

Valuation

See full
Market cap$923.31M+259%
Enterprise value$700.21M+179%
P/S159.6×+87.1×

Profitability

See full
Net margin-2,895.4%-257pp
FCF margin-2,619.5%+69.9pp

Returns & leverage

See full
Return on equity-158.9%-26.4pp
Debt / equity-2.5×
Current ratio4.8×+4.0×

Where this comes from

Calculated from DBV Technologies’s reported figures.

Based on trailing twelve months.

The official record: DBV Technologies’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about DBV Technologies's operating margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is DBV Technologies's operating margin?
DBV Technologies (DBVT) reported operating margin of -2,910.4% in Q1 2026.
How has DBV Technologies's operating margin changed year-over-year?
DBV Technologies's operating margin increased by 10.0% year-over-year, from -3,234.5% to -2,910.4%.
What is the long-term trend for DBV Technologies's operating margin?
Over 3 years (2021 to 2025), DBV Technologies's operating margin has grown at a 14.4% compound annual growth rate (CAGR), from -1,727.6% to -2,586.9%.
What does operating margin mean?
Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.